PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2026Neuroscience Letters2 citationsOpen Access

Cromolyn inhibits PGE2-mediated sensitisation of TRPV1 in a GPR35-dependent manner in sensory neurons

View Full Paper
JHJames P. HighamLPLuke W PaineACAlanna Cameron

Key Points

  • To investigate the anti-nociceptive effects of cromolyn and its mechanism involving GPR35 in sensory neurons.
  • Utilized ratiometric Ca2+ imaging to study sensory neurons
  • Examined the effects of PGE2 in the presence of cromolyn
  • Investigated the GPR35 dependency of the inhibition on TRPV1 sensitisation
  • Cromolyn effectively inhibited PGE2-mediated TRPV1 sensitisation
  • The inhibition demonstrated a clear dependence on GPR35 activity
  • Supports the potential of GPR35 as a target for developing new analgesics

Abstract

There is a pressing need for effective alternatives to opioid analgesics, the development of which requires the identification of novel anti-nociceptive drug targets. Here, we have further investigated the anti-nociceptive properties of a GPR35 agonist, cromolyn, in an in vitro model of inflammatory sensitisation. We used ratiometric Ca 2+ imaging of cultured sensory neurons to examine the effect of cromolyn on prostaglandin E 2 (PGE 2 )-mediated sensitisation of the pro-nociceptive ion channel, transient receptor potential cation channel, subfamily V, member 1 (TRPV1). The sensitisation of TRPV1 by PGE 2 was inhibited by cromolyn in a GPR35-dependent manner. These observations provide further evidence in support of an anti-nociceptive role for GPR35, highlighting the potential use of GPR35 agonists as analgesics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Higham et al. (2026) studied this question.

synapsesocial.com/papers/69be35f96e48c4981c67495ehttps://doi.org/10.1016/j.neulet.2026.138585
Ask AI
Helpful
Bookmark
Share
View Full Paper